BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 35879396)

  • 61. Mucins in cancer: function, prognosis and therapy.
    Kufe DW
    Nat Rev Cancer; 2009 Dec; 9(12):874-85. PubMed ID: 19935676
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vivo pharmacodynamic imaging of proteasome inhibition.
    Kimbrel EA; Davis TN; Bradner JE; Kung AL
    Mol Imaging; 2009; 8(3):140-7. PubMed ID: 19723471
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The structure and function of G-protein-coupled receptors.
    Rosenbaum DM; Rasmussen SG; Kobilka BK
    Nature; 2009 May; 459(7245):356-63. PubMed ID: 19458711
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis.
    Gueorguiev M; Grossman AB
    Pituitary; 2009; 12(3):245-55. PubMed ID: 18946739
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clonogenic assay of cells in vitro.
    Franken NA; Rodermond HM; Stap J; Haveman J; van Bree C
    Nat Protoc; 2006; 1(5):2315-9. PubMed ID: 17406473
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The many faces of H89: a review.
    Lochner A; Moolman JA
    Cardiovasc Drug Rev; 2006; 24(3-4):261-74. PubMed ID: 17214602
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase.
    Taurin S; Sandbo N; Qin Y; Browning D; Dulin NO
    J Biol Chem; 2006 Apr; 281(15):9971-6. PubMed ID: 16476742
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination.
    Hino S; Tanji C; Nakayama KI; Kikuchi A
    Mol Cell Biol; 2005 Oct; 25(20):9063-72. PubMed ID: 16199882
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
    Subramanian A; Tamayo P; Mootha VK; Mukherjee S; Ebert BL; Gillette MA; Paulovich A; Pomeroy SL; Golub TR; Lander ES; Mesirov JP
    Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15545-50. PubMed ID: 16199517
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.
    Landis CA; Masters SB; Spada A; Pace AM; Bourne HR; Vallar L
    Nature; 1989 Aug; 340(6236):692-6. PubMed ID: 2549426
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review.
    Lin YL; Ma R; Li Y
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2179-2188. PubMed ID: 32700107
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Physiological dysfunctions associated with mutations of the imprinted Gnas locus.
    Krechowec S; Plagge A
    Physiology (Bethesda); 2008 Aug; 23():221-9. PubMed ID: 18697996
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The G protein Gαs acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis.
    Rao R; Salloum R; Xin M; Lu QR
    Cell Cycle; 2016 May; 15(10):1325-30. PubMed ID: 27052725
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mucinous Adenocarcinoma With Intrapulmonary Metastasis Harboring KRAS and GNAS Mutations Arising in Congenital Pulmonary Airway Malformation.
    de Cordova XF; Wang H; Mehrad M; Eisenberg R; Johnson J; Wei Q; Borinstein S; Danko ME; Liang J
    Am J Clin Pathol; 2021 Jul; 156(2):313-319. PubMed ID: 33609098
    [TBL] [Abstract][Full Text] [Related]  

  • 76. GNAS imprinting and pituitary tumors.
    Mantovani G; Lania AG; Spada A
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):15-8. PubMed ID: 20398730
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Minireview: GNAS: normal and abnormal functions.
    Weinstein LS; Liu J; Sakamoto A; Xie T; Chen M
    Endocrinology; 2004 Dec; 145(12):5459-64. PubMed ID: 15331575
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oncogene addiction to GNAS in GNAS
    More A; Ito I; Haridas V; Chowdhury S; Gu Y; Dickson P; Fowlkes N; Shen JP
    Oncogene; 2022 Aug; 41(35):4159-4168. PubMed ID: 35879396
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.